BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Decision Resources Group 

260 Charles Street

Waltham  Massachusetts  02453  U.S.A.
Phone: 781-296-2500 Fax: 781-296-2550


SEARCH JOBS




Industry
Services






 Company News
Decision Resources Group To Host Biosimilars Seminar In London 3/26/2014 8:38:33 AM
Diane Corrado Joins Decision Resources Group As Executive Vice President, Sales And Marketing 3/11/2014 9:19:52 AM
Courtney Morris Joins Decision Resources Group as Executive Vice President, Solutions 9/10/2013 6:27:16 AM
Decision Resources Group Release: A Focus on Specialty Pharmacy at Las Vegas Pharmaceutical Conference 8/15/2012 9:55:47 AM
Decision Resources Group Release: Keynote Speakers Announced for Sixth Annual Pinsonault Managed Markets Summit 7/26/2012 10:06:53 AM
Decision Resources Group Release: Competition for Early-Line Biologic Use Among Psoriasis Patients Intensifies as Humira Continues to Gain Ground on Enbrel 10/5/2011 8:52:45 AM
Decision Resources Group Release: Over the Next Decade, the Malignant Melanoma Drug Market Will Increase More Than Seven-Fold to $1.5 Billion in 2020 10/4/2011 8:48:48 AM
Decision Resources Group Release: Biosimilar Versions of TNF-alpha Inhibitors and Pegylated IFN-alpha Agents Will Save Healthcare Systems $5.3 Billion in 2020 10/3/2011 9:56:31 AM
Decision Resources Group Acquires PharmaStrat 7/25/2011 10:46:53 AM
Decision Resources, Inc. Finds Despite FDA Label Revisions Regarding LABA-Containing Drugs, Patient Share of LABA/ICS Combination Drugs Exceed Patient Share of Single-Agent ICS Drugs in Recently Treated Asthma Patients 7/20/2011 6:55:19 AM
12